How to best assess quality of drug treatment in patients with heart failure.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 965, doi. 10.1007/s00228-016-2052-y
- By:
- Publication type:
- Article
Works matching IS 00316970 AND DT 2016 AND VI 72 AND IP 8
Results: 14
1
2
Carbamazepine and oxcarbazepine: reflections after an oxcarbazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
- Published in:
- 2016
- By:
- Publication type:
- Letter
3
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 1025, doi. 10.1007/s00228-016-2073-6
- By:
- Publication type:
- Article
4
Pharmacokinetics study of mazindol in plasma, oral fluid, and urine of volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 945, doi. 10.1007/s00228-016-2055-8
- By:
- Publication type:
- Article
5
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 905, doi. 10.1007/s00228-016-2083-4
- By:
- Publication type:
- Article
6
Persistent analgesic use and the association with chronic pain and other risk factors in the population-a longitudinal study from the Tromsø Study and the Norwegian Prescription Database.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 977, doi. 10.1007/s00228-016-2056-7
- By:
- Publication type:
- Article
7
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 953, doi. 10.1007/s00228-016-2057-6
- By:
- Publication type:
- Article
8
Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 987, doi. 10.1007/s00228-016-2058-5
- By:
- Publication type:
- Article
9
Pro re nata (as needed) medication in nursing homes: the longer you stay, the more you get?
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 995, doi. 10.1007/s00228-016-2059-4
- By:
- Publication type:
- Article
10
Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 917, doi. 10.1007/s00228-016-2062-9
- By:
- Publication type:
- Article
11
Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 1003, doi. 10.1007/s00228-016-2064-7
- By:
- Publication type:
- Article
12
No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 925, doi. 10.1007/s00228-016-2065-6
- By:
- Publication type:
- Article
13
Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 933, doi. 10.1007/s00228-016-2040-2
- By:
- Publication type:
- Article
14
Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 8, p. 1013, doi. 10.1007/s00228-016-2068-3
- By:
- Publication type:
- Article